|
市場調査レポート
商品コード
1064730
心停止治療の世界市場:2021年~2027年Cardiac Arrest Treatment Market 2021-2027 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
心停止治療の世界市場:2021年~2027年 |
出版日: 2022年01月30日
発行: Orion Market Research
ページ情報: 英文 111 Pages
納期: 2~3営業日
|
世界の心停止治療の市場規模は、予測期間中に大幅なCAGRで拡大すると予測されています。座りがちな生活習慣、肥満、糖尿病、喫煙、高コレステロール、高血圧などが、世界の心停止治療市場の成長に大きく寄与しています。
当レポートでは、世界の心停止治療市場について調査し、市場の概要とともに、治療タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。Global Cardiac Arrest Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Drugs, Medical Devices), Forecast (2021 - 2027)
The global cardiac arrest treatment market is anticipated to grow at a considerable CAGR during the forecast period. Higher inclination towards sedentary lifestyle, obesity, diabetes mellitus, smoking, high cholesterol, and high blood pressure among others are the key contributors to the growth of the global cardiac arrest treatment market.
The global cardiac arrest treatment market is segmented based on treatment type. Based on treatment type, the cardiac arrest treatment market is segmented into drug and medical device. The drugs are further sub-segmented into vasopressors, corticosteroid, anti-arrhythmic drugs, and others. The medical device segment is further sub-segmented into defibrillator, cardiac resynchronization therapy, and others.
Geographically, the global cardiac arrest treatment market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global cardiac arrest treatment market include ZOLL Medical Corp., General Electric Co., Abbott Laboratories, Stryker Corp., Boston Scientific Corp., and Koninklijke Philips N.V. among others.
Market Segmentation
The Report Covers